Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)

Historical Holders from Q4 2023 to Q2 2025

Symbol
JSPR on Nasdaq
CUSIP
471871202
Type / Class
Equity / Voting Common Stock, par value $0.0001 per share
Shares outstanding
27.8M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
12.5M
Holdings value
$69.5M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
63
Number of buys
32
Number of sells
-35
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Velan Capital Investment Management LP 9.6% $7.58M 2.67M Velan Capital Investment Management LP Sep 19, 2025
Soleus Capital Master Fund, L.P. 9.96% $5.41M 1.49M Soleus Capital Management, L.P. Dec 31, 2024
KINGDON CAPITAL MANAGEMENT, L.L.C. 5.1% $3.46M 765K KINGDON CAPITAL MANAGEMENT, L.L.C. Jul 3, 2025
MORGAN STANLEY 5% $3.43M 758K Morgan Stanley Jun 30, 2025
BlackRock, Inc. 1.5% $1.02M 226K BlackRock, Inc. Jun 30, 2025

Institutional Holders of Jasper Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (JSPR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 12.5M $69.5M -$2.54M $5.55 63
2025 Q1 13M $56M -$70.6M $4.30 66
2024 Q4 15.6M $334M +$15M $21.38 84
2024 Q3 14.7M $275M -$5.49M $18.81 77
2024 Q2 14.6M $330M +$34.9M $22.70 68
2024 Q1 13M $379M +$359M $29.36 56
2023 Q4 495K $390K +$390K $0.79 1